ISMP Links Invokana to Ketoacidosis

Written By:
Jessie Paluch
Jessie Paluch

Attorney Jessie Paluch, founder of TruLaw, has over 25 years of experience as a personal injury and mass tort attorney, and previously worked as an international tax attorney at Deloitte. Jessie collaborates with attorneys nationwide — enabling her to share reliable, up-to-date legal information with our readers.

This article has been written and reviewed for legal accuracy and clarity by the team of writers and legal experts at TruLaw and is as accurate as possible. This content should not be taken as legal advice from an attorney. If you would like to learn more about our owner and experienced injury lawyer, Jessie Paluch, you can do so here.

TruLaw does everything possible to make sure the information in this article is up to date and accurate. If you need specific legal advice about your case, contact us by using the chat on the bottom of this page. This article should not be taken as advice from an attorney.

ISMP Links Invokana to Ketoacidosis

According to theInstitute for Safe Medication Practices (ISMP), an analysis of FDA adverse event data from 2015 revealed that more than 630 reports of ketoacidosis involving Invokana patients had been logged by the agency’s database that year.

ISMP also noted that Invokana received more serious adverse event reports than 92% of the drugs it regularly monitors.

invokana ketoacidosis linked
Table of Contents

Invokana and Diabetic Ketoacidosis – FDA Safety Alerts

Since coming on the market, Invokana and other SGLT2 inhibitors have been the subject of multiple FDA safety alerts:

  • In September 2015, the FDA announced that the labels for Invokana and Invokamet would be updated to include information about a possible increased risk of bone fractures.
  • In December 2015,the drugs’ labels were updated to reflect the potential for diabetic ketoacidosis as well as life-threatening blood infections like urosepsis and kidney infections like pyelonephritis that originate as urinary tract infections.
  • In May 2016, the FDA was investigating a possible link between the use of Invokana and Invokamet and an increased incidence of leg and foot amputations, mostly affecting the toes.
  • Last month, theFDA orderedthe manufacturers of Invokana, Invokamet, Farxiga and Xigduo XR to strengthen label warnings regarding kidney complications potentially associated with their use after the drugs were cited in over 100 reports of acute kidney injury.

What Is Invokana?

Invokana is part of a class of prescription medicines known as Sodium-glucose Cotransporter-2 (SGLT2) Inhibitors approved by the U.S. Food and Drug Administration (FDA). 

Canagliflozin is the active ingredient found in both Invokana and Invokamet. 

It is a prescription medication used in combination with diet and exercise to lower blood sugar in adults with type 2 diabetes.

It is available as a single-ingredient product under the brand name Invokana and also in combination with the diabetes medicine metformin under the brand name Invokamet.

SGLT2 inhibitors like Invokana, Invokamet Farxiga, and Jardiance work by preventing the absorption of glucose by the kidneys, thus facilitating its removal from the body via urine.

Written By:
Jessie Paluch
Jessie Paluch

Experienced Attorney & Legal SaaS CEO

With over 25 years of legal experience, Jessie is an Illinois lawyer, a CPA, and a mother of three.  She spent the first decade of her career working as an international tax attorney at Deloitte.

In 2009, Jessie co-founded her own law firm with her husband – which has scaled to over 30 employees since its conception.

In 2016, Jessie founded TruLaw, which allows her to collaborate with attorneys and legal experts across the United States on a daily basis. This hypervaluable network of experts is what enables her to share reliable legal information with her readers!

Camp Lejeune Lawsuit

Camp Lejeune’s water contamination issue spanned several decades starting in the 1950s. Exposure to these chemicals has been linked to various serious health issues, including cancer, organ diseases, and death.

Tylenol Lawsuit

Research is increasingly suggesting a link between the use of Tylenol during pregnancy and the development of neurodevelopmental disorders, such as autism and ADHD, in infants.

AFFF Lawsuit

Legal action is being taken against manufacturers of Aqueous Film-Forming Foam (AFFF), a chemical used in fighting fires. The plaintiffs allege that exposure to the foam caused health issues such as cancer, organ damage, and birth and fertility issues.

Do You
Have A Case?

Here, at TruLaw, we’re committed to helping victims get the justice they deserve.

Alongside our partner law firms, we have successfully collected over $3 Billion in verdicts and settlements on behalf of injured individuals.

Would you like our help?

Helpful Sites & Resources